Effect of Bandage Compliance on Upper Extremity Volume in Patients with Breast Cancer-Related Lymphedema

Ergin, Gülbin; Şahinoğlu, Ertan; Karadibak, Didem; Yavuzşen, Tuğba

doi:10.1089/lrb.2017.0060

Cited by 7 publications

(6 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…First, we did not assess the type, duration, and adherence to compressive bandage treatment during follow-up, which could influence the effectiveness of lymphedema treatment [ 37 ]. Self-bandaging using a short stretch bandage is more challenging and the compliance rate is low [ 38 , 39 ]. Therefore, a prospective study is required to evaluate the relationship between compliance to treatment and impact on fibrosis.…”

Section: Discussionmentioning

confidence: 99%

Temporal Changes in Subcutaneous Fibrosis in Patients with Lower Extremity Lymphedema Following Surgery for Gynecologic Cancer: A Computed Tomography-Based Quantitative Analysis

Lee

Kim

2022

Diagnostics

View full text Add to dashboard Cite

Lymphedema causes inflammation, which provokes fibrosis within the epifascial tissue. Temporal change in fibrosis according to severity of the lymphedema has not been widely investigated. We aimed to study the quantitative changes in epifascial fibrosis during lymphedema treatment using computed tomography (CT). Forty-five patients (mean age: 57.75 ± 11.12 years) who developed lymphedema following gynecologic surgery were included in this retrospective study. Two weeks of complete decongestive therapy and continued self-bandaging or compression garments were prescribed under regular follow-up monitoring. Lower-extremity epifascial fibrosis was quantitatively analyzed on the initial and follow-up CT scans. Circumference, skin fibrosis, subcutaneous tissue, and fibrosis ratio were calculated in the axial scan. Based on the change in lymphedema severity, we divided subjects into ‘improved’ and ‘aggravated’ groups. The affected lower extremities showed higher circumference, more skin fibrosis and subcutaneous tissue, and higher fibrosis ratio than the unaffected sides on initial CT scan. At follow-up, compared to the aggravated group, the improved group showed significant decreases in fibrosis of skin and subcutaneous tissue and fibrosis ratio. Subcutaneous fibrosis was reversible with volume resolution of lymphedema. Therapeutic approaches should be established on the basis of the reversible nature of fibrotic changes in patients with lower extremity lymphedema.

show abstract

Section: Discussionmentioning

confidence: 99%

Temporal Changes in Subcutaneous Fibrosis in Patients with Lower Extremity Lymphedema Following Surgery for Gynecologic Cancer: A Computed Tomography-Based Quantitative Analysis

Lee

Kim

2022

Diagnostics

View full text Add to dashboard Cite

show abstract

“…Intensive CDP therapy involves MLLB [72]. Twelve hours per day is a sufficient duration to apply bandaging [78]. NMLB may also significantly reduce both swelling and swelling-related symptoms [79].…”

Section: Discussionmentioning

confidence: 99%

“…They thus insisted on the need for a uniform curriculum of training courses including measurement of the bandaging pressure. Erglin et al researched the ideal duration for applying bandaging [78]. They divided the average number of hours of bandage compliance into 2 groups: 13–24 and 7–12 h. No significant difference in the volume reduction was noted between the two groups.…”

Section: Treatmentsmentioning

confidence: 99%

Development and Themes of Diagnostic and Treatment Procedures for Secondary Leg Lymphedema in Patients with Gynecologic Cancers

et al. 2019

View full text Add to dashboard Cite

Patients with leg lymphedema sometimes suffer under constraint feeling leg heaviness and pain, requiring lifelong treatment and psychosocial support after surgeries or radiation therapies for gynecologic cancers. We herein review the current issues (a review of the relevant literature) associated with recently developed diagnostic procedures and treatments for secondary leg lymphedema, and discuss how to better manage leg lymphedema. Among the currently available diagnostic tools, indocyanine green lymphography (ICG-LG) can detect dermal lymph backflow in asymptomatic legs at stage 0. Therefore, ICG-LG is considered the most sensitive and useful tool. At symptomatic stage ≥1, ultrasonography, magnetic resonance imaging-lymphography/computed tomography-lymphography (MRI-LG/CT-LG) and lymphosintiography are also useful. For the treatment of lymphedema, complex decongestive physiotherapy (CDP) including manual lymphatic drainage (MLD), compression therapy, exercise and skin care, is generally performed. In recent years, CDP has often required effective multi-layer lymph edema bandaging (MLLB) or advanced pneumatic compression devices (APCDs). If CDP is not effective, microsurgical procedures can be performed. At stage 1–2, when lymphaticovenous anastomosis (LVA) is performed, lymphaticovenous side-to-side anastomosis (LVSEA) is principally recommended. At stage 2–3, vascularized lymph node transfer (VLNT) is useful. These ingenious procedures can help maintain the patient’s quality of life (QOL) but unfortunately cannot cure lymphedema. The most important concern is the prevention of secondary lymphedema, which is achieved through approaches such as skin care, weight control, gentle limb exercises, avoiding sun and heat, and elevation of the affected leg.

show abstract

“…The multilayer bandage included a tubular cotton bandage (Tubigrip®), a 10‐cm‐wide and 2‐mm‐thick foam bandage (Texafoam®) and a short 8‐cm‐wide stretch bandage (Rosidal®K). These were applied in a spiral shape, overlapping every two thirds, and with decreasing compression from the knuckles to the axilla (Ergin et al, 2018). Fingers showing lymphedema were dressed in a 4‐cm‐wide non‐cohesive elastic bandage (Elastomull®).…”

Section: Methodsmentioning

confidence: 99%

Intensive complex physical therapy combined with intermittent pneumatic compression versus Kinesio taping for treating breast cancer‐related lymphedema of the upper limb: A randomised cross‐over clinical trial

Otero

Delgado

Cortijo

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

Objective: The objective of this study is to compare the effectiveness of complex physical therapy combined with intermittent pneumatic compression (CPT + IPC) versus Kinesio taping (KT) for breast cancer-related lymphedema. Methods: A cross-over clinical trial was conducted in 43 women with lymphedema. All participants received two interventions: CPT + IPC and KT, both lasting 3 weeks and a washout period. The main outcome variable was the relative volume change (RVC). The secondary variables were Satisfaction Questionnaire about Textile Therapeutic Devices used for Breast Cancer-Related Lymphedema, Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, motion range of upper limb and lymphedema-related symptoms.Results: The RVC reduction was greater with CPT + IPC (À2.2%, SD = 4.7) versus KT (À0.9%, SD = 1.7) (P = 0.002). KT was more satisfactory than multilayer bandaging (8.9 points difference, P < 0.001) and improved DASH score more than CPT + IPC (14.3 points difference, P = 0.002). Regarding motion ranges, only shoulder

show abstract

Effect of Bandage Compliance on Upper Extremity Volume in Patients with Breast Cancer-Related Lymphedema

Cited by 7 publications

References 20 publications

Temporal Changes in Subcutaneous Fibrosis in Patients with Lower Extremity Lymphedema Following Surgery for Gynecologic Cancer: A Computed Tomography-Based Quantitative Analysis

Temporal Changes in Subcutaneous Fibrosis in Patients with Lower Extremity Lymphedema Following Surgery for Gynecologic Cancer: A Computed Tomography-Based Quantitative Analysis

Development and Themes of Diagnostic and Treatment Procedures for Secondary Leg Lymphedema in Patients with Gynecologic Cancers

Intensive complex physical therapy combined with intermittent pneumatic compression versus Kinesio taping for treating breast cancer‐related lymphedema of the upper limb: A randomised cross‐over clinical trial

Contact Info

Product

Resources

About